eXoZymes Inc. entered into an Underwriting Agreement with MDB Capital on June 5, 2026, to conduct a firm commitment underwritten offering of 592,270 shares of common stock and 292,135 warrants. The offering price per unit was $18.00, with expected gross proceeds of approximately $5,330,430.
